185 related articles for article (PubMed ID: 35712020)
1. Context-dependant enhancers as a reservoir of functional polymorphisms and epigenetic markers linked to alcohol use disorders and comorbidities.
MacKenzie A; Hay EA; McEwan AR
Addict Neurosci; 2022 Jun; 2():None. PubMed ID: 35712020
[TBL] [Abstract][Full Text] [Related]
2. Perspective: Quality Versus Quantity; Is It Important to Assess the Role of Enhancers in Complex Disease from an In Vivo Perspective?
McEwan AR; MacKenzie A
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33113946
[TBL] [Abstract][Full Text] [Related]
3. Overview of the Genetics of Alcohol Use Disorder.
Tawa EA; Hall SD; Lohoff FW
Alcohol Alcohol; 2016 Sep; 51(5):507-14. PubMed ID: 27445363
[TBL] [Abstract][Full Text] [Related]
4. Diverse types of genomic evidence converge on alcohol use disorder risk genes.
Dai Y; Hu R; Pei G; Zhang H; Zhao Z; Jia P
J Med Genet; 2020 Nov; 57(11):733-743. PubMed ID: 32170004
[TBL] [Abstract][Full Text] [Related]
5. The anxiety and ethanol intake controlling GAL5.1 enhancer is epigenetically modulated by, and controls preference for, high-fat diet.
McEwan A; Erickson JC; Davidson C; Heijkoop J; Turnbull Y; Delibegovic M; Murgatroyd C; MacKenzie A
Cell Mol Life Sci; 2021 Mar; 78(6):3045-3055. PubMed ID: 33313982
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic Dysregulation in Alcohol-Associated Behaviors: Preclinical and Clinical Evidence.
Domi E; Barchiesi R; Barbier E
Curr Top Behav Neurosci; 2023 Jan; ():. PubMed ID: 36717533
[TBL] [Abstract][Full Text] [Related]
7. Three-dimensional genome architectural CCCTC-binding factor makes choice in duplicated enhancers at Pcdhα locus.
Wu Y; Jia Z; Ge X; Wu Q
Sci China Life Sci; 2020 Jun; 63(6):835-844. PubMed ID: 32249388
[TBL] [Abstract][Full Text] [Related]
8. In the loop: promoter-enhancer interactions and bioinformatics.
Mora A; Sandve GK; Gabrielsen OS; Eskeland R
Brief Bioinform; 2016 Nov; 17(6):980-995. PubMed ID: 26586731
[TBL] [Abstract][Full Text] [Related]
9. Integrative analysis of liver-specific non-coding regulatory SNPs associated with the risk of coronary artery disease.
Selvarajan I; Toropainen A; Garske KM; López Rodríguez M; Ko A; Miao Z; Kaminska D; Õunap K; Örd T; Ravindran A; Liu OH; Moreau PR; Jawahar Deen A; Männistö V; Pan C; Levonen AL; Lusis AJ; Heikkinen S; Romanoski CE; Pihlajamäki J; Pajukanta P; Kaikkonen MU
Am J Hum Genet; 2021 Mar; 108(3):411-430. PubMed ID: 33626337
[TBL] [Abstract][Full Text] [Related]
10. Variation in the Untranslated Genome and Susceptibility to Infections.
Ramsuran V; Ewy R; Nguyen H; Kulkarni S
Front Immunol; 2018; 9():2046. PubMed ID: 30245696
[TBL] [Abstract][Full Text] [Related]
11. Review: DNA methylation and alcohol use disorders: Progress and challenges.
Zhang H; Gelernter J
Am J Addict; 2017 Aug; 26(5):502-515. PubMed ID: 27759945
[TBL] [Abstract][Full Text] [Related]
12. Recent advances in genetic studies of alcohol use disorders.
Gupta I; Dandavate R; Gupta P; Agrawal V; Kapoor M
Curr Genet Med Rep; 2020 Jun; 8(2):27-34. PubMed ID: 33344068
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic modification in alcohol use disorder and alcoholic cardiomyopathy: From pathophysiology to therapeutic opportunities.
Wu L; Zhang Y; Ren J
Metabolism; 2021 Dec; 125():154909. PubMed ID: 34627873
[TBL] [Abstract][Full Text] [Related]
14. Integrative Analysis of Genetic, Genomic, and Phenotypic Data for Ethanol Behaviors: A Network-Based Pipeline for Identifying Mechanisms and Potential Drug Targets.
Bogenpohl JW; Mignogna KM; Smith ML; Miles MF
Methods Mol Biol; 2017; 1488():531-549. PubMed ID: 27933543
[TBL] [Abstract][Full Text] [Related]
15. Assessment of the Association of D2 Dopamine Receptor Gene and Reported Allele Frequencies With Alcohol Use Disorders: A Systematic Review and Meta-analysis.
Jung Y; Montel RA; Shen PH; Mash DC; Goldman D
JAMA Netw Open; 2019 Nov; 2(11):e1914940. PubMed ID: 31702801
[TBL] [Abstract][Full Text] [Related]
16. Functional annotation of colon cancer risk SNPs.
Yao L; Tak YG; Berman BP; Farnham PJ
Nat Commun; 2014 Sep; 5():5114. PubMed ID: 25268989
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic aging is accelerated in alcohol use disorder and regulated by genetic variation in APOL2.
Luo A; Jung J; Longley M; Rosoff DB; Charlet K; Muench C; Lee J; Hodgkinson CA; Goldman D; Horvath S; Kaminsky ZA; Lohoff FW
Neuropsychopharmacology; 2020 Jan; 45(2):327-336. PubMed ID: 31466081
[TBL] [Abstract][Full Text] [Related]
18. Allele-specific enhancers mediate associations between LCAT and ABCA1 polymorphisms and HDL metabolism.
Howard AD; Wang X; Prasad M; Sahu AD; Aniba R; Miller M; Hannenhalli S; Chang YC
PLoS One; 2019; 14(4):e0215911. PubMed ID: 31039173
[TBL] [Abstract][Full Text] [Related]
19. Enhancer Dysfunction in 3D Genome and Disease.
Xia JH; Wei GH
Cells; 2019 Oct; 8(10):. PubMed ID: 31635067
[TBL] [Abstract][Full Text] [Related]
20. Characterisation of non-coding genetic variation in histamine receptors using AnNCR-SNP.
Rojano E; Ranea JA; Perkins JR
Amino Acids; 2016 Oct; 48(10):2433-42. PubMed ID: 27270572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
